Private Wealth Partners LLC Has Cut Caredx INC (CDNA) Stake by $11.08 Million as Stock Value Rose

September 30, 2018 - By Mark Babin

Investors sentiment decreased to 1.82 in Q2 2018. Its down 1.32, from 3.14 in 2018Q1. It turned negative, as 13 investors sold CDNA shares while 21 reduced holdings. 41 funds opened positions while 21 raised stakes. 25.40 million shares or 30.38% less from 36.48 million shares in 2018Q1 were reported. Macquarie Gp Limited holds 21,300 shares or 0% of its portfolio. Howe And Rusling reported 100 shares. Blackrock reported 2.26M shares. Ameritas Ptnrs has invested 0% in CareDx, Inc (NASDAQ:CDNA). Driehaus Mgmt Limited Co has 398,615 shares. Eam Ltd reported 143,501 shares. Cambridge Advsr Inc has 0.01% invested in CareDx, Inc (NASDAQ:CDNA). Perkins Mngmt has invested 1.77% of its portfolio in CareDx, Inc (NASDAQ:CDNA). Piedmont Invest Advisors Ltd Liability Corporation stated it has 561 shares. Quantbot Tech LP reported 3,183 shares. Clear Harbor Asset Mngmt Limited Liability Company has invested 0.04% in CareDx, Inc (NASDAQ:CDNA). Fred Alger Mngmt has 0.17% invested in CareDx, Inc (NASDAQ:CDNA) for 3.26 million shares. 118,714 are held by Tiaa Cref Inv Mngmt Limited. Perceptive Advsr Llc accumulated 0.15% or 467,676 shares. Moreover, Teton Advisors has 0.02% invested in CareDx, Inc (NASDAQ:CDNA).

Since March 27, 2018, it had 1 buying transaction, and 4 insider sales for $1.29 million activity. On Tuesday, September 4 Maag Peter sold $346,542 worth of CareDx, Inc (NASDAQ:CDNA) or 15,000 shares. The insider GAGNON NEIL bought $95,481. King Sasha sold $132,735 worth of stock. On Thursday, September 13 the insider Bell Michael Brian sold $409,920.

Private Wealth Partners Llc decreased its stake in Caredx Inc (CDNA) by 98.82% based on its latest 2018Q2 regulatory filing with the SEC. Private Wealth Partners Llc sold 923,500 shares as the company’s stock rose 69.22% with the market. The institutional investor held 11,000 shares of the health care company at the end of 2018Q2, valued at $135,000, down from 934,500 at the end of the previous reported quarter. Private Wealth Partners Llc who had been investing in Caredx Inc for a number of months, seems to be less bullish one the $1.05B market cap company. The stock increased 5.06% or $1.39 during the last trading session, reaching $28.85. About 571,917 shares traded or 0.23% up from the average. CareDx, Inc (NASDAQ:CDNA) has risen 830.40% since September 30, 2017 and is uptrending. It has outperformed by 814.78% the S&P500.

Analysts await CareDx, Inc (NASDAQ:CDNA) to report earnings on November, 8. They expect $-0.13 earnings per share, up 23.53 % or $0.04 from last year’s $-0.17 per share. After $-0.11 actual earnings per share reported by CareDx, Inc for the previous quarter, Wall Street now forecasts 18.18 % negative EPS growth.

More notable recent CareDx, Inc (NASDAQ:CDNA) news were published by: Nasdaq.com which released: “CareDx to Participate in Upcoming Investor Conference” on September 21, 2018, also Benzinga.com with their article: “The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron” published on September 27, 2018, Seekingalpha.com published: “Canaccord bullish on medical diagnostic firms” on September 14, 2018. More interesting news about CareDx, Inc (NASDAQ:CDNA) were released by: Benzinga.com and their article: “The Daily Biotech Pulse: Verastem’s Chinese Duvelisib Licensing Deal, Aldeyra’s Positive Dry Eye Disease Drug Trial” published on September 26, 2018 as well as Globenewswire.com‘s news article titled: “CareDx broadens HeartCare availability” with publication date: September 17, 2018.

CareDx, Inc (NASDAQ:CDNA) Ratings Coverage

Among 2 analysts covering CareDx (NASDAQ:CDNA), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. CareDx had 6 analyst reports since April 2, 2018 according to SRatingsIntel. Piper Jaffray maintained the shares of CDNA in report on Wednesday, June 6 with “Buy” rating. As per Friday, May 11, the company rating was maintained by H.C. Wainwright. On Monday, April 2 the stock rating was maintained by H.C. Wainwright with “Buy”. The company was maintained on Thursday, April 12 by H.C. Wainwright. H.C. Wainwright downgraded CareDx, Inc (NASDAQ:CDNA) on Tuesday, June 19 to “Hold” rating. The rating was maintained by Piper Jaffray on Monday, May 21 with “Buy”.

CareDx, Inc (NASDAQ:CDNA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: